Genomic Health, Inc. Enters Oversold Territory

Zacks

Genomic Health, Inc.’s (GHDX) share price has entered into oversold territory with a stochastic value of 11.3322. The Zacks Consensus Estimate on the company’s earnings for year ending December 2012 increased by 2 cents over the past month to 18 cents per share. Genomic Health, Inc. is a Zacks #2 Rank (“Buy”) company.

 

GENOMIC HEALTH INC (GHDX): Free Stock Analysis Report

Zacks Investment Research



More From Zacks.com

Rates

View Comments (0)